Simultaneous dual-target magnetic resonance-guided focused ultrasound treatment for patients with tremor-dominant Parkinson’s disease
- Authors: Galimova R.M.1,2, Illarioshkin S.N.3, Akhmadeeva G.N.1,2, Nabiullina D.I.2, Kashapov F.F.2, Safin S.M.1, Buzaev I.V.1,2, Teregulova D.R.2, Sidorova Y.A.2, Kachemaeva O.V.1,2
-
Affiliations:
- Bashkir State Medical University
- Intellectual Neurosurgery Clinic, V.S. Buzaev International Medical Center
- Research Center of Neurology
- Issue: Vol 18, No 2 (2024)
- Pages: 5-12
- Section: Original articles
- URL: https://journals.rcsi.science/2075-5473/article/view/262412
- DOI: https://doi.org/10.17816/ACEN.1085
- ID: 262412
Cite item
Abstract
Introduction. Non-invasive magnetic resonance-guided focused ultrasound (MRgFUS) is a new neurosurgical treatment option for tremor-dominant Parkinson’s disease (TDPD). Outcomes of ablation with dual targeting of two subcortical nuclei to improve functional treatment results are yet to be explored.
Aim. This study aimed to evaluate the safety and efficacy of MRgFUS with simultaneous unilateral ablation of two cerebral targets in patients with TDPD.
Materials and methods. A total of 82 TDPD patients (20 women, 62 men; median age 65.0 [52.5; 70,0] years) received unilateral MRgFUS, i.e. ventrointermedial (VIM) nucleus thalamotomy and/or pallidothalamotractotomy (PTT). Motor symptoms, including tremor, were assessed using MDS-Unified Parkinson’s Disease Rating Scale Part III (MDS-UPDRS-III). VIM, PTT, and VIM + PTT ablation was received by 34, 12, and 36 patients, respectively.
Results. After surgery, MDS-UPDRS-III score improved by 40.1% (30.2; 51.7) without early or late-onset serious complications. Tremor returned in 18 patients (all after VIM thalamotomy); 9 of them successfully underwent re-treatment 9–12 months after the first procedure. Simultaneous dual-target (VIM + PPT) intervention was successfully received by 36 patients without any serious complications. A total of 89.3% and 69.7% of patients remained relapse-free in the dual-target and single-target groups, respectively (p = 0.039).
Conclusion. Simultaneous dual-target (VIM and PTT) MRgFUS showed favorable safety and efficacy profiles and can be considered a symptomatic treatment option for TDPD patients.
Full Text
##article.viewOnOriginalSite##About the authors
Rezida M. Galimova
Bashkir State Medical University; Intellectual Neurosurgery Clinic, V.S. Buzaev International Medical Center
Author for correspondence.
Email: rezida@galimova.com
ORCID iD: 0000-0003-2758-0351
Cand. Sci. (Med.), Department of neurosurgery, Bashkir State Medical University; chief, neurosurgeon, Intelligent Neurosurgery Clinic, International Medical Center V.S. Buzaev Memorial
Russian Federation, Ufa; UfaSergey N. Illarioshkin
Research Center of Neurology
Email: annaly-nevrologii@neurology.ru
ORCID iD: 0000-0002-2704-6282
D. Sci. (Med.), Prof., RAS Full Member, Director, Brain Institute, Deputy director, Research Center of Neurology
Russian Federation, MoscowGulnara N. Akhmadeeva
Bashkir State Medical University; Intellectual Neurosurgery Clinic, V.S. Buzaev International Medical Center
Email: nevrolog.ufa@gmail.com
ORCID iD: 0000-0001-5516-0587
Cand. Sci. (Med.), Department of neurology, Bashkir State Medical University; neurologist, Intelligent Neurosurgery Clinic, International Medical Center V.S. Buzaev Memorial
Russian Federation, Ufa; UfaDinara I. Nabiullina
Intellectual Neurosurgery Clinic, V.S. Buzaev International Medical Center
Email: Nabiullina.Dinara@yandex.ru
ORCID iD: 0000-0003-2570-3709
neurologist, Intelligent Neurosurgery Clinic, International Medical Center V.S. Buzaev Memorial
Russian Federation, UfaFelix F. Kashapov
Intellectual Neurosurgery Clinic, V.S. Buzaev International Medical Center
Email: felix.kashapov@mail.ru
ORCID iD: 0000-0003-3355-4096
neurologist, Intelligent Neurosurgery Clinic, International Medical Center V.S. Buzaev Memorial
Russian Federation, UfaShamil M. Safin
Bashkir State Medical University
Email: safinsh@mail.ru
ORCID iD: 0000-0002-0100-6100
D. Sci. (Med.), Prof., Head, Department of neurosurgery, Bashkir State Medical University
Russian Federation, UfaIgor V. Buzaev
Bashkir State Medical University; Intellectual Neurosurgery Clinic, V.S. Buzaev International Medical Center
Email: igor@buzaev.com
ORCID iD: 0000-0003-0511-9345
D. Sci. (Med.), Prof., Surgery department, Bashkir State Medical University; cardiovascular surgeon, Intelligent Neurosurgery Clinic, International Medical Center V.S. Buzaev Memorial
Russian Federation, Ufa; UfaDinara R. Teregulova
Intellectual Neurosurgery Clinic, V.S. Buzaev International Medical Center
Email: dinamail@mail.ru
ORCID iD: 0000-0001-6283-3735
Cand. Sci. (Med.), neurologist, Intelligent Neurosurgery Clinic, International Medical Center V.S. Buzaev Memorial
Russian Federation, UfaYulia A. Sidorova
Intellectual Neurosurgery Clinic, V.S. Buzaev International Medical Center
Email: yuliasi.ufa@gmail.com
ORCID iD: 0000-0002-0992-0239
neurologist, Intelligent Neurosurgery Clinic, International Medical Center V.S. Buzaev Memorial
Russian Federation, UfaOlga V. Kachemaeva
Bashkir State Medical University; Intellectual Neurosurgery Clinic, V.S. Buzaev International Medical Center
Email: olga.kachemaeva@gmail.com
ORCID iD: 0000-0001-9949-9582
Cand. Sci. (Med.), Associate Professor, Department of neurology, Bashkir State Medical University; neurologist, Intelligent Neurosurgery Clinic, International Medical Center V.S. Buzaev Memorial
Russian Federation, Ufa; UfaReferences
- Иллариошкин С.Н., Иванова-Смоленская И.А. Дрожательные гиперкинезы. Руководство для врачей. М.; 2011.
- Богданов Р.Р., Богданов А.Р., Котов С.В. Тактика ведения пациентов с начальными проявлениями болезни Паркинсона. Доктор.Ру. 2012;(5):15–21.
- Левин О.С., Иллариошкин С.Н., Артемьев Д.В. Диагностика болезни Паркинсона. В кн.: Иллариошкин С.Н., Левин О.С. (ред.) Руководство по диагностике и лечению болезни Паркинсона. М.; 2017:34–98.
- Simon D.K., Tanner C.M., Brundin P. Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin. Geriatr. Med. 2020;36(1):1–12. doi: 10.1016/j.cger.2019.08.002
- Dorsey E.R., Sherer T., Okun M.S., Bloem B.R. The emerging evidence of the Parkinson pandemic. J. Parkinsons Dis. 2018;8(s1):3–8. doi: 10.3233/JPD-181474
- Kaltenboeck A., Johnson S.J., Davis M.R. Direct costs and survival of medicare beneficiaries with early and advanced Parkinson’s disease. Parkinsonism Relat. Disord. 2012;18(4):321–326. doi: 10.1016/j.parkreldis.2011.11.015
- Иванов П.И., Зубаткина И.С., Бутовская Д.А., Кожокарь Т.И. Радиохирургическое лечение резистентного к медикаментозной терапии тремора при болезни Паркинсона. Нейрохирургия. 2021;23(1):16–25.
- Иллариошкин С.Н. Современные подходы к лечению болезни Паркинсона. Нервные болезни. 2004;(4):14–21.
- Kostiuk K., Lomadze V., Vasyliv N. Stereotactic thalamotomy and contralateral subthalamotomy in treatment of Parkinson's disease. Georgian Med. News. 2017;(272):12–17.
- Гуща А.О., Тюрников В.М., Кащеев А.А. Современные возможности хирургической нейромодуляции. Анналы клинической и экспериментальной неврологии. 2018;12(5S):32–37.
- Холявин А.И., Аничков А.Д., Шамрей В.К. Функциональная нейрохирургия в лечении нервных и психических заболеваний. СПб.; 2018.
- Галимова Р.М., Набиуллина Д.И., Иллариошкин С.Н. и др. Первый в России опыт лечения пациентов с эссенциальным тремором методом фокусированного ультразвука под контролем МРТ. Анналы клинической и экспериментальной неврологии. 2022;16(2):5–14.
- Christian E., Yu C., Apuzzo M.L. Focused ultrasound: relevant history and prospects for the addition of mechanical energy to the neurosurgical armamentarium. World Neurosurg. 2014;82(3-4):354–365.
- Dobrakowski P.P., Machowska-Majchrzak A.K., Labuz-Roszak B. MR-guided focused ultrasound: a new generation treatment of Parkinson's disease, essential tremor and neuropathic pain. Interv. Neuroradiol. 2014;20(3):275–282.
- Ohye C., Hirai T., Miyazaki M. Vim thalamotomy for the treatment of various kinds of tremor. Appl. Neurophysiol. 1982;45(3):275–280.
- Гамалея А.А., Томский А.А., Поддубская А.А. и др. Эффективность двусторонней электростимуляции внутреннего сегмента бледного шара в лечении сегментарной и генерализованной форм дистонии. Медицинский алфавит. 2017;1(2):47–55.
- Хабарова Е.А., Пилипенко П.И., Денисова Н.П., Ефремов Ф.А. Сравнительная эффективность нейростимуляции субталамического ядра и стереотаксических деструктивных вмешательств на подкорковых структурах головного мозга у пациентов с болезнью Паркинсона. Нервные болезни. 2023;(2):12–18.
- Томский А.А., Бриль Е.В., Гамалея А.А. и др. Функциональная нейрохирургия при болезни Паркинсона в России. Анналы клинической и экспериментальной неврологии. 2019;13(4):10–15.
- Fasano A., De Vloo P., Llinas M. et al. Magnetic resonance imaging-guided focused ultrasound thalamotomy in Parkinson tremor: reoperation after benefit decay. Mov. Disord. 2018;33(5):848–849. doi: 10.1002/mds.27348
- Gallay M.N., Moser, D., Magara A.E. et al. Bilateral MR-guided focused ultrasound pallidothalamic tractotomy for Parkinson’s disease with 1-year follow up. Front. Neurol. 2021;12:601153. doi: 10.3389/fneur.2021.601153
- Sperling S.A., Shah B.B., Barrett M.J. Focused ultrasound thalamotomy in Parkinson disease: nonmotor outcomes and quality of life. Neurology. 2018;91(14):e1275–e1284. doi: 10.1212/WNL.0000000000006279
- Bond A.E., Shah B.B., Huss D.S. Safety and efficacy of focused ultrasound thalamotomy for patients with medication-refractory, tremor-dominant Parkinson disease: a randomized clinical trial. JAMA Neurol. 2017;74(12):1412–1418.
- Sinai A., Nassar M., Sprecher E. Focused ultrasound thalamotomy in tremor dominant Parkinson's disease: long-term results. J. Parkinsons Dis. 2022;12(1):199–206. doi: 10.3233/JPD-212810
- Milosevic L., Kalia S.K., Hodaie M. et al. Physiological mechanisms of thalamic ventral intermediate nucleus stimulation for tremor suppression. Brain. 2018;141(7):2142–2155. doi: 10.1093/brain/awy139
- Martínez-Fernández R., Máñez-Miró J.U., Rodríguez-Rojas R. et al. Randomized trial of focused ultrasound subthalamotomy for Parkinson's disease. N. Engl. J. Med. 2020;383(26):2501–2513. doi: 10.1056/NEJMoa2016311
- Speelman J.D., Schuurman R., de Bie R.M. et al. Stereotactic neurosurgery for tremor. Mov. Disord. 2002;17(Suppl. 3):84–88. doi: 10.1002/mds.10147
- Gallay M.N., Moser D., Rossi F. et al. MRgFUS pallidothalamic tractotomy for chronic therapy-resistant Parkinson's disease in 51 consecutive patients: single center experience. Front. Surg. 2020;6:76. doi: 10.3389/fsurg.2019.00076
- Jui-Cheng C., Ming-Kuei L., Chun-Ming C., Chon-Haw T. Stepwise dual-target magnetic resonance–guided focused ultrasound in tremor-dominant Parkinson disease: a feasibility study. World Neurosurg. 2023;171:e464–e470. doi: 10.1016/j.wneu.2022.12.049
- Berardelli A., Wenning G.K., Antonini A. et al. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease. Eur. J. Neurol. 2013;20(1):16–34.
- Bhidayasiri R. Parkinson’s disease: Hoehn and Yahr scale. In: Bhidayasiri R., Tarsy D. Movement disorders: a Video Atlas. Springer; 2012.
- The Unified Parkinson's Dsease Rating Scale (UPDRS): status and recommendations. Mov. Disord. 2003;18(7):738–750. doi: 10.1002/mds.10473
- Смоленцева И.Г., Амосова Н.А. Применение международной классификации функционирования в реабилитации при болезни Паркинсона. Кремлевская медицина. 2018;(3):49–54.
- Иллариошкин С.Н., Коновалов Р.Н., Федотова Е.Ю., Москаленко А.Н. Новые МРТ-методики в диагностике болезни Паркинсона: оценка нигральной дегенерации. Анналы клинической и экспериментальной неврологии; 2019;13(4):77–84.
- Богданов Р.Р., Мананникова Е.И., Абраменко А.С. и др. Визуализация дофаминергических структур среднего мозга при болезни Паркинсона. Анналы клинической и экспериментальной неврологии. 2013;7(3):31–36.
- Tzu-Hsiang K., Yu-Hsuan L., Lung C. et al. Magnetic resonance–guided focused ultrasound surgery for Parkinson's disease: a mini-review and comparison between deep brain stimulation. Parkinsonism Relat. Disord. 2023;111:105431.